Skip to content

Is apathy associated with poor effort during neuropsychological assessment in patients with Alzheimer*s disease or Parkinson*s disease?

Is apathy associated with poor effort during neuropsychological assessment in patients with Alzheimer*s disease or Parkinson*s disease? - Apathy and effort during neuropsychological assessment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37992
Enrollment
180
Registered
2011-03-29
Start date
2011-05-18
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effort

Interventions

None listed

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: M. Parkinson: diagnosis according to the United Kingdom Parkinson*s Disease Society Brain Bank criteria.;Dementia: diagnosis of possible or probable Alzheimer*s disease according to NINCDS-ADRDA criteria. ;Mental competency to give informed consent. Mental competency as defined by the Dutch law (WGBO; Wet op Geneeskundige Behandel Overeenkomst) is determined by the medical specialist (psychiatrist, neurologist). ;Native Dutch speaker;A minimum of 8 years of formal schooling and no history of mental retardation

Exclusion criteria

Exclusion criteria: Mini Mental State Examination (MMSE)

Design outcomes

Primary

MeasureTime frame
The difference in performance on the following symptom validity tests: Test of Memory Malingering (TOMM), Dot Counting Test (DCT) and Structured Inventory of Malingering Symptoms (SIMS) between patients with and without apathy. For more detailed information on the symptom valdity tests, we refer to section 7.3 Study procedures (p.14-15) of the research protocol.

Secondary

MeasureTime frame
Relationship between the scores on TOMM, Dot Counting and SIMS and those on neuropsychological tests. The difference in cognitive complaints as measured with the Cognitive Failure Questionnaire (CFQ, see section 7.3, page 16, of the research protocol for more detailed information) between patients with and without apathy.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)